Newmark Arranges $300M Joint Venture Between Catalyst and Heitman
Rhea-AI Summary
Newmark Group, Inc. (Nasdaq: NMRK) has arranged a strategic joint venture between Catalyst Healthcare Real Estate and Heitman, securing $300 million to fund the development of purpose-built healthcare properties. The initial phase includes funding seven developments totaling nearly 500,000 square feet across five states, with tenants like Ochsner Health and Andrews Medicine.
The venture aims to develop medical outpatient buildings, orthopedic centers of excellence, and inpatient rehabilitation facilities. This partnership marks a significant milestone in Heitman's 20+ year history of investing in the medical office sector, leveraging the counter-cyclical qualities of this needs-based asset class.
Positive
- Secured $300 million funding for healthcare property development
- Initial phase includes 7 developments totaling nearly 500,000 square feet
- Partnership with blue chip tenants like Ochsner Health and Andrews Medicine
- Expansion into a counter-cyclical, needs-based asset class
Negative
- None.
News Market Reaction 1 Alert
On the day this news was published, NMRK gained 4.32%, reflecting a moderate positive market reaction.
Data tracked by StockTitan Argus on the day of publication.
The transaction was led by Newmark's Healthcare Capital Markets group Executive Managing Director Ben Appel, Senior Managing Director John Nero, Executive Managing Director Jay Miele, Senior Managing Director Michael
The initial phase includes funding seven ground-up or in-process developments totaling nearly 500,000 square feet, spanning five states and encompassing blue chip tenants such as Ochsner Health, Andrews Medicine, University of Mississippi Medical Center and PAM Health.
"Catalyst works in partnership with its clients to design comprehensive real estate solutions that best support their mission, vision and values of providing better access to care, higher quality outcomes and lasting relationships," said Chad Henderson, Founder/CEO and Managing Partner of Catalyst Healthcare Real Estate.
"The joint venture with Catalyst is another significant milestone in Heitman's 20+ year history of investing in the medical office sector," said Brian Pieracci, Heitman Head of Private Equity –
"Catalyst prides itself on its people, its promise and the quality of its work," added Appel. "The firm has been recognized nationally for both its people, including CEO Chad Henderson, and for the quality of its developments."
"Supporting the growth of many of the nation's leading providers, the Venture further solidifies Catalyst's business plan to execute its ambulatory strategy," added Nero.
About Newmark
Newmark Group, Inc. (Nasdaq: NMRK), together with its subsidiaries ("Newmark"), is a world leader in commercial real estate, seamlessly powering every phase of the property life cycle. Newmark's comprehensive suite of services and products is uniquely tailored to each client, from owners to occupiers, investors to founders, and startups to blue-chip companies. Combining the platform's global reach with market intelligence in both established and emerging property markets, Newmark provides superior service to clients across the industry spectrum. For the year ended December 31, 2023, Newmark generated revenues of approximately
Discussion of Forward-Looking Statements about Newmark
Statements in this document regarding Newmark that are not historical facts are "forward-looking statements" that involve risks and uncertainties, which could cause actual results to differ from those contained in the forward-looking statements. These include statements about the Company's business, results, financial position, liquidity, and outlook, which may constitute forward-looking statements and are subject to the risk that the actual impact may differ, possibly materially, from what is currently expected. Except as required by law, Newmark undertakes no obligation to update any forward-looking statements. For a discussion of additional risks and uncertainties, which could cause actual results to differ from those contained in the forward-looking statements, see Newmark's Securities and Exchange Commission filings, including, but not limited to, the risk factors and Special Note on Forward-Looking Information set forth in these filings and any updates to such risk factors and Special Note on Forward-Looking Information contained in subsequent reports on Form 10-K, Form 10-Q or Form 8-K.
About Catalyst Healthcare Real Estate
Catalyst is a national healthcare real estate development and investment firm. Our platform of integrated real estate deliverables is specifically designed for the ever-evolving landscape of healthcare real estate. Our team seeks to positively impact healthcare with strategic investment in development, acquisition, and strategy services. For more information, please visit catalysthre.com.
About Heitman
Heitman is a global real estate investment management firm with
View original content to download multimedia:https://www.prnewswire.com/news-releases/newmark-arranges-300m-joint-venture-between-catalyst-and-heitman-302218175.html
SOURCE Newmark Group, Inc.